Management of Sickle Cell Disease

20141,526 citationsReview

Authors

Barbara P. Yawn · Olmsted Medical Center

George R. Buchanan · The University of Texas Southwestern Medical Center

Araba Afenyi‐Annan · University of North Carolina at Chapel Hill

Samir K. Ballas · Thomas Jefferson University

Kathryn L. Hassell · University of Colorado Denver

Allison James · University of Virginia

Lanetta Jordan

Abstract

Hydroxyurea and transfusion therapy are strongly recommended for many individuals with SCD. Many other recommendations are based on quality of evidence that is less than high due to the paucity of clinical trials regarding screening, management, and monitoring for individuals with SCD.

Topics & Keywords

Hemoglobinopathies and Related Disorders Iron Metabolism and Disorders Bone and Joint Diseases

Publication Details

Published in: JAMA

Volume 312, Issue 10, pp. 1033-1033

DOI: 10.1001/jama.2014.10517

Field-Weighted Citation Impact: 65.00

Command Palette

Management of Sickle Cell Disease

Authors

Abstract

Topics & Keywords

Publication Details